LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_177438.3:c.1510-4dupT
DICER1
· NP_803187.1:p.?
· NM_177438.3
GRCh37: chr14:95583035 G>GA
·
GRCh38: chr14:95116698 G>GA
Gene:
DICER1
Transcript:
NM_177438.3
Final call
Benign
BA1 stand-alone benign
BS1 strong
BS2 supporting
Variant details
Gene
DICER1
Transcript
NM_177438.3
Protein
NP_803187.1:p.?
gnomAD AF
0.0014255479633815227 (v4.1)
ClinVar
Benign
OncoKB
Classification rationale
Interpretation summary
Generated evidence synthesis
1
Benign: BA1 is stand-alone because the African/African American gnomAD v4.1 allele frequency is 0.0131239.
2
Benign: BS1 is strong because the African/African American gnomAD v4.1 allele frequency is 0.0131239 with 935 variant alleles.
3
Benign: BS2 is supporting because gnomAD v4.1 reports six homozygous observations without clinical information.
Final determination:
The DICER1 VCEP Version 1.4 point-based framework assigns Benign at a total score of -7 or below; BA1 (-8), BS1 (-4), and BS2 (-1) total -13.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: c.1510-4dup is intronic at -4, outside the DICER1 VCEP PVS1 scope of nonsense/frameshift and canonical +/-1 or +/-2 splice variants. |
cspec
vcep_pvs1_decisiontree
spliceai
|
| PS1 | Not assessed | Not assessed: no pathogenic DICER1 VCEP comparator at the same nucleotide or amino-acid change is documented for c.1510-4dupT. |
cspec
spliceai
|
| PS2 | Not assessed | Not assessed: no documented parental testing or confirmed de novo observation is available to calculate the DICER1 VCEP PS2 point total. |
cspec
|
| PS3 | Not assessed | Not assessed: no variant-specific RNA or cleavage assay with validated controls and quantitative functional result is available for c.1510-4dupT. |
cspec
|
| PS4 | Not assessed | Not assessed: no phenotype-point total or case-control enrichment result is available for NM_177438.3:c.1510-4dup. |
cspec
|
| PM1 | N/A | Not applicable: c.1510-4dupT is intronic with protein consequence p.?, not a missense variant in an approved DICER1 critical domain. |
cspec
|
| PM2 | Not met | Not met: gnomAD v4.1 overall AF 0.00142555 is far above the DICER1 VCEP PM2 threshold of <0.000005, with 2,181 observed alleles. |
cspec
gnomad_v4
gnomad_v2
|
| PM3 | N/A | Not applicable: the DICER1 VCEP explicitly designates PM3 as not applicable for this autosomal-dominant disorder. |
cspec
|
| PM4 | N/A | Not applicable: c.1510-4dup is intronic with protein consequence p.?, not an in-frame coding indel eligible for the DICER1 VCEP PM4 rule. |
cspec
|
| PM5 | N/A | Not applicable: c.1510-4dupT is intronic with protein consequence p.?, so no same-residue missense comparison can be made. |
cspec
pm5_candidates
|
| PM6 | N/A | Not applicable: the DICER1 VCEP explicitly directs reviewers to use PS2 instead of PM6 for de novo evidence. |
cspec
|
| PP1 | Not assessed | Not assessed: no affected relatives or documented segregation data are available to establish even the minimum 3–4 meioses required for PP1 Supporting. |
cspec
|
| PP2 | N/A | Not applicable: the DICER1 VCEP marks PP2 not applicable, and c.1510-4dupT is intronic rather than missense. |
cspec
|
| PP3 | Not assessed | Not assessed: SpliceAI max delta 0.016 is below PP3 thresholds, but the DICER1 rule requires concordant MaxEntScan, which is unavailable. |
cspec
spliceai
|
| PP4 | Not assessed | Not assessed: COSMIC reports 2 somatic occurrences, but no qualifying RNase IIIb second-hit and retention data are provided. |
cspec
|
| PP5 | N/A | Not applicable: the DICER1 VCEP excludes PP5, and ClinVar has 0 expert-panel submissions for this exact variant. |
cspec
clinvar
|
| BA1 | Met | Met: gnomAD v4.1 African/African American AF 0.0131239 exceeds the DICER1 VCEP BA1 threshold of >0.003 with 935/71,244 alleles. |
cspec
gnomad_v4
|
| BS1 | Met | Met, strong: gnomAD v4.1 African/African American AF 0.0131239 exceeds the DICER1 VCEP BS1 threshold of >0.0003 with 935/71,244 alleles. |
cspec
gnomad_v4
|
| BS2 | Met | Met, supporting: gnomAD v4.1 reports 6 homozygotes, meeting the DICER1 VCEP requirement of at least 2 homozygous observations without clinical information. |
cspec
gnomad_v4
|
| BS3 | Not assessed | Not assessed: no variant-specific RNA or cleavage assay with replication, validated controls, and demonstrated normal function is available for c.1510-4dupT. |
cspec
|
| BS4 | Not assessed | Not assessed: no phenotype-positive genotype-negative relatives or documented non-segregation observation is available for the DICER1 BS4 rule. |
cspec
|
| BP1 | N/A | Not applicable: the DICER1 VCEP marks BP1 not applicable, and c.1510-4dupT is intronic rather than missense. |
cspec
|
| BP2 | Not assessed | Not assessed: no affected-proband co-occurrence or phase evidence documents the VCEP threshold of one trans observation or three cis/unknown observations. |
cspec
|
| BP3 | N/A | Not applicable: the DICER1 VCEP Version 1.4 explicitly designates BP3 as not applicable, regardless of this intronic duplication's repeat context. |
cspec
|
| BP4 | Not assessed | Not assessed: SpliceAI max delta 0.016 is below the BP4 threshold, but the DICER1 rule requires concordant MaxEntScan, which is unavailable. |
cspec
spliceai
|
| BP5 | N/A | Not applicable: the DICER1 VCEP Version 1.4 explicitly excludes BP5 for this gene framework. |
cspec
|
| BP6 | N/A | Not applicable: the DICER1 VCEP excludes BP6, and ClinVar has 0 expert-panel submissions for this exact variant. |
cspec
clinvar
|
| BP7 | N/A | Not applicable: c.1510-4dup is an intronic splice-region variant, not a synonymous coding variant, so BP7 is outside scope. |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.